Clinical trial
A Prospective, Randomized, Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Transcatheter Aortic Valve Implantation in Female Patients Who Have Severe Symptomatic Aortic Stenosis Requiring Aortic Valve Replacement
NCT04160130 is registered in ClinicalTrials.gov with Optimapharm as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Transcatheter Aortic Valve Implantation in Female Patients Who Have Severe Symptomatic Aortic Stenosis Requiring Aortic Valve Replacement
- Lead sponsor
- Optimapharm
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 29, 2019
- Completion date
- June 30, 2024
- Enrollment
- 432 (actual)
- Sites
- 48
Conditions
As the registry lists them; a condition with its own page is linked.